Curaleaf Continues Florida Expansion with Port Orange Dispensary Opening
Curaleaf Holdings (CURLF) will open its Port Orange dispensary to medical cannabis patients on October 21, 2026, expanding its Florida presence.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Curaleaf Holdings (CURLF) will open its Port Orange dispensary to medical cannabis patients on October 21, 2026, expanding its Florida presence. The location at 1760 Dunlawton Avenue, Unit 5, brings its retail footprint to 80 stores in Florida and 190 nationwide.
The dispensary adds a location in Volusia County. Grand opening celebrations are scheduled for October 30 and 31, with special offers and giveaways while supplies last. Store hours will be Monday through Saturday, 9:00 a.m. to 8:30 p.m. ET, and Sunday, 10:00 a.m. to 7:00 p.m. ET.
AI-generated analysis. How Rhea-AI works. Not financial advice.
New location brings the Company's
Curaleaf Port Orange expands the Company's presence in
The store will offer a wide range of products, including Curaleaf's
"Opening in
Curaleaf Port Orange will host grand opening celebrations on October 30 and 31, 2026, featuring special offers and giveaways while supplies last. The first 25 patients with a valid medical card each day will receive a free eighth of flower with a
The store will operate Monday through Saturday from 9:00 A.M. to 8:30 P.M. ET and on Sunday from 10:00 A.M. to 7:00 P.M. ET.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, FIND, Dark Heart, and Anthem, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Port Orange, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the Company with respect to the matter described in this news release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-continues-florida-expansion-with-port-orange-dispensary-opening-302913685.html
SOURCE Curaleaf Holdings, Inc.